Quinazolines: Combined type 3 and 4 phosphodiesterase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 20, 1998, Pages 2891-2896

  Charpiot, Brigitte ^a   Brun, Jvan ^a   Donze, Irene ^a   Naef, Reto ^a   Stefani, Monique ^a   Mueller, Thomas ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DICYCLOPROPYLMETHOXYOXYPHENYLQUINAZOLINE; PHOSPHODIESTERASE INHIBITOR; QUINAZOLINE DERIVATIVE; ROLIPRAM; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CONFORMATION; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; STRUCTURE ACTIVITY RELATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; HUMANS; INHIBITORY CONCENTRATION 50; PHOSPHODIESTERASE INHIBITORS; QUINAZOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032552909     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00508-3     Document Type: Article

References (31)

1. 1. Giembycz, M. A.; Dent, G. Clin. Exp. Allergy 1992, 22, 337-344.
2. 2. Giembycz, M. A. Biochem. Pharmacol. 1992, 43, 2041-2051.
3. 3. Nicholson, C. D.; Shahid, M. Pulmon. Pharmacol. 1994, 7, 1-17.
4. 4. Beavo, J. A. Adv. Second Messenger Phosphoprotein Res. 1988, 22, 1-38.
5. 5. Beavo, J.A.; Conti, M.; Heaslip, R. J. Mol. Pharmacol. 1994, 46, 399-405.
6. 6. Engels, P.; Fichtel, K.; Lübbert, H. FEBS Lett. 1994, 350, 291-295.
7. 7. Colicelli, J.; Birchmeir, C.; Michaeli, T.; O'Neil, K.; Riggs, M.; Wigler, M. Proc. Natl. Acad. Sci. USA 1989, 86, 3599-3603.
8. 8. Davis, R. L.; Takayasu, H.; Eberwine, M.; Myres, J. Proc. Natl. Acad. sci. USA 1989, 86, 3604-3608.
9. 9. Swinnen, J. V.; Joseph, D. R.; Conti, M. Proc. Natl. Acad. Sci. USA 1989, 86, 5325-5329.
10. 10. Bolger, G.; Michaeli, T.; Martins, T.; St. John, T.; Steiner, B.; Rodgers, L.; Riggs, M.; Wrigler, M.; Fergusson, K. Mol. Cell. Biol. 1993, 13, 6558-6751.
11. 11. Obernote, R.; Bhakta, S.; Alvarez, R.; Bach, C.; Zuppan, P.; Mukins, M.; Jarnagin, K.; Shelton, E. R. Gene 1993, 129, 239-247.
12. 12. Sette, C. E.; Vicini, M.; Conti, J. Biol. Chem. 1994, 269, 1-8.
13. 13. Schudt, C.; Winder, S.; Eltze, M.; Kilian, U.; Beume, R. Agents Action 1991, 34, 379-402.
14. 14. Sanjar, S.; Aoki, S.; Boubekeur, K.; Chapman, I. D.; Smith, D.; Kings, M. A.; Morley, J. Br. J. Pharmacol. 1990, 99, 267-272.
15. 15. Brunnee, T.; Engelstätter, R.; Steinijans, V. W.; Kundel, G.; Eur. Resp. J. 1992, 5, 982-985.
16. 16. Foster, R. W.; Rakshi, K. Br. J. Pharmacol. 1990, 99, 193P.
17. 17. 2,4-Dichloro-6,7-dimethoxyquinazoline available from Lancaster.
18. 18. Krebs, A.; Hagemann, H. US 4, 777, 283, 1988
19. 19. Cremshaw, R. R.; Luke, G. M.; Partyka, R. A. US 4, 102, 885, 1978
20. 20. 20a) Andrievskii, A. M.; Gorelik, M. V.; Aviden, S. V.; Al'Tman, E. Sh. Zh. Org. Khim. 1993, 29, 1828-1834.
21. 20b) Effenberger, F.; Koch, M.; Streicher, W. Chem. Ber. 1991, 124, 163-173. 20c)
22. 20c) Depaulis, T.; Smith, H. E., Synthetic Commun. 1991, 21, 1091-1095.
23. 24
24. 24
25. 23. Sullivan M.; Egerton M.; Shakur Y.; Marquardsen A.; Houslay M.D. Cell. Signal 1994, 6, 793-812.
26. 24. Engels, P.; Sullivan, M.; Müller, T.; Lübbert, H. FEBS Lett 1995, 358, 305-310.
27. 25. Baecker, P. A.; Obernolte, R.; Bach, C.; Yee, C.; Shelton, E. R. Gene 1994, 138, 253-256.
28. 28
29. 27. Bradford, M. M. Anal. Biochem. 1976, 72, 248-254
30. 28. Schneider, H. H.; Schmiechen, R.; Brezinski, M.; Seidler, J. Eur. J. Pharmacol 1992, 127, 105-115.
31. 29. Kelly, J.J.; Barnes, P. J., Giembycz, M.A. Biochem. J. 1996, 318, 425-36.